Article Information
History
- July 22, 2021.
Article Versions
- You are currently viewing Version 1 of this article (July 22, 2021 - 17:42).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Zijun Wang1,
- Siya Zhao2,
- Yuyi Tang3,
- Zhili Wang3,
- Qianling Shi4,
- Xiangyang Dang3,
- Lidan Gan3,
- Shuai Peng3,
- Weiguo Li3,
- Qi Zhou5,
- Qinyuan Li3,
- Joy James Mafiana2,
- Rafael Gonzalez Cortes6,
- Zhengxiu Luo3,
- Enmei Liu3 and
- Yaolong Chen7,8 (chevidence{at}lzu.edu.cn)
- 1 Lanzhou University;
- 2 School of Public Health, Lanzhou University;
- 3 Department of Respiratory Medicine, Childrens Hospital of Chongqing Medical University;
- 4 The First School of Clinical Medicine, Lanzhou University;
- 5 Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University;
- 6 Paediatric Intensive Care Unit, Hospital General Universitario Gregorio Maranon;
- 7 Evidence-based Medicine Center, School of Basic Medical Sciences
- ↵* Corresponding author; email: chevidence{at}lzu.edu.cn
Posted July 22, 2021.
Potentially effective drugs for the treatment of COVID-19 in children: a systematic review
